Mätlik, Kärt http://orcid.org/0000-0003-1777-5614
Garton, Daniel R.
Montaño-Rodríguez, Ana R.
Olfat, Soophie
Eren, Feride http://orcid.org/0000-0001-6068-5329
Casserly, Laoise
Damdimopoulos, Anastasios
Panhelainen, Anne
Porokuokka, L. Lauriina
Kopra, Jaakko J.
Turconi, Giorgio
Schweizer, Nadine
Bereczki, Erika
Piehl, Fredrik http://orcid.org/0000-0001-8329-5219
Engberg, Göran http://orcid.org/0000-0003-1659-5232
Cervenka, Simon http://orcid.org/0000-0001-8103-6977
Piepponen, T. Petteri http://orcid.org/0000-0002-2318-1612
Zhang, Fu-Ping
Sipilä, Petra
Jakobsson, Johan http://orcid.org/0000-0003-0669-7673
Sellgren, Carl M.
Erhardt, Sophie http://orcid.org/0000-0001-7359-5250
Andressoo, Jaan-Olle http://orcid.org/0000-0002-0271-3157
Article History
Received: 14 June 2021
Revised: 24 March 2022
Accepted: 25 March 2022
First Online: 26 May 2022
Change Date: 8 June 2022
Change Type: Update
Change Details: Supplementary Methods and Supplementary Tables link are switched.
Competing interests
: CMS is a scientific advisor to Outermost Therapeutics Inc. The rest of the authors declare that they have no competing interests.